4//SEC Filing
Schramm Vern Lee 4
Accession 0001415889-19-000012
CIK 0001604191other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 6:01 PM ET
Size
4.8 KB
Accession
0001415889-19-000012
Insider Transaction Report
Form 4
Schramm Vern Lee
Director
Transactions
- Award
Common Stock
2018-12-28$1.29/sh+7,500$9,675→ 37,500 total
Footnotes (1)
- [F1]Shares issued in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ending December 31, 2018.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001719553
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 6:01 PM ET
- Size
- 4.8 KB